BofA lowered the firm’s price target on Kenvue (KVUE) to $27 from $30 and keeps a Buy rating on the shares. The firm is tweaking estimates lower ahead of Q3 earnings due on October 26, citing higher public company costs and other costs associated with the J&J (JNJ) separation, and applying a lower EBITDA multiple due to peer group multiple compression.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on KVUE:
- RBC Analyst Bullish on Johnson & Johnson (NYSE: JNJ) Post-Spinoff
- Kenvue price target lowered to $26 from $29 at JPMorgan
- CART, CAVA, or ARM: Which 2023 IPO Stock Does Wall Street Find Attractive?
- Notable open interest changes for September 26th
- Procter & Gamble Stock (NYSE:PG): Quality Comes at a Hefty Price